Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

02/08/2024 07:02

Aug 2 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.88                1.86                      
                 (+1.3 pct)          (-8.1 pct)                   
  Operating      loss 89 mln         loss 57 mln                  
  Recurring      loss 64 mln         loss 28 mln                  
  Net            loss 11 mln           100 mln                    
  EPS           loss 0.32 yen         2.90 yen                    
  Ann Div                             3.00 yen                    
  -Q2 div                                NIL                      
  -Q4 div                             3.00 yen                    
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T